Atracurium Besylate
NDC 0409-1109, ATRACURIUM BESYLATE, injection, solution, from Hospira, Inc..
- Product NDC
- 0409-1109
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090782
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-1109-01 | 00409110901 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1109-01) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-1109-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/de1c2dcd-295b-47ce-b7a1-a8be59939a54
Use it
Look up 0409-1109 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-1109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.